These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
565 related articles for article (PubMed ID: 18974782)
21. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Ferre AL; Hunt PW; Critchfield JW; Young DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL Blood; 2009 Apr; 113(17):3978-89. PubMed ID: 19109229 [TBL] [Abstract][Full Text] [Related]
22. Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection. Sester M; Sester U; Köhler H; Schneider T; Deml L; Wagner R; Mueller-Lantzsch N; Pees HW; Meyerhans A AIDS; 2000 Dec; 14(17):2653-60. PubMed ID: 11125883 [TBL] [Abstract][Full Text] [Related]
23. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count. Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838 [TBL] [Abstract][Full Text] [Related]
24. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. Ferre AL; Hunt PW; McConnell DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL J Virol; 2010 Nov; 84(21):11020-9. PubMed ID: 20719952 [TBL] [Abstract][Full Text] [Related]
25. Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression. Maina EK; Abana CZ; Bukusi EA; Sedegah M; Lartey M; Ampofo WK Cytokine; 2016 May; 81():109-16. PubMed ID: 26986868 [TBL] [Abstract][Full Text] [Related]
26. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children. Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588 [TBL] [Abstract][Full Text] [Related]
27. Alteration of CD8+ T cell effector diversity during HIV-1 infection with discordant normalization in effective antiretroviral therapy. Onlamoon N; Sukapirom K; Polsrila K; Ammaranond P; Pattanapanyasat K Cytometry B Clin Cytom; 2012 Jan; 82(1):35-42. PubMed ID: 21915993 [TBL] [Abstract][Full Text] [Related]
28. Poor lymphoproliferative responses with low proportion of Gag-specific CD8 TEMRA cells in HIV-1-infected patients showing immunological and virological discordance despite prolonged suppression of plasma viremia. Sachdeva N; Weinstein JE; Ashman M; Sachdeva M; Brewer TH; Gracia D; Asthana D Viral Immunol; 2010 Feb; 23(1):49-61. PubMed ID: 20121402 [TBL] [Abstract][Full Text] [Related]
29. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915 [TBL] [Abstract][Full Text] [Related]
30. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy. Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968 [TBL] [Abstract][Full Text] [Related]
31. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients. Allers K; Puyskens A; Epple HJ; Schürmann D; Hofmann J; Moos V; Schneider T Mucosal Immunol; 2016 Jan; 9(1):265-74. PubMed ID: 26129649 [TBL] [Abstract][Full Text] [Related]
32. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients. Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174 [TBL] [Abstract][Full Text] [Related]
33. HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57. Jensen SS; Tingstedt JL; Larsen TK; Brandt L; Gerstoft J; Kronborg G; Pedersen C; Fomsgaard A; Karlsson I J Acquir Immune Defic Syndr; 2016 Jan; 71(1):8-16. PubMed ID: 26761268 [TBL] [Abstract][Full Text] [Related]
34. Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load. Oxenius A; Sewell AK; Dawson SJ; Günthard HF; Fischer M; Gillespie GM; Rowland-Jones SL; Fagard C; Hirschel B; Phillips RE; Price DA; J Clin Immunol; 2002 Nov; 22(6):363-74. PubMed ID: 12462336 [TBL] [Abstract][Full Text] [Related]
35. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. Shaw JM; Hunt PW; Critchfield JW; McConnell DH; Garcia JC; Pollard RB; Somsouk M; Deeks SG; Shacklett BL J Virol; 2011 Nov; 85(21):11422-34. PubMed ID: 21880771 [TBL] [Abstract][Full Text] [Related]
36. Phenotype, Polyfunctionality, and Antiviral Activity of Salido J; Ruiz MJ; Trifone C; Figueroa MI; Caruso MP; Gherardi MM; Sued O; Salomón H; Laufer N; Ghiglione Y; Turk G Front Immunol; 2018; 9():2443. PubMed ID: 30405632 [TBL] [Abstract][Full Text] [Related]
37. HIV-specific T-cell responses detected in the genital tract of chronically HIV-infected women are largely monofunctional. Bere A; Denny L; Naicker P; Burgers WA; Passmore JA Immunology; 2013 Jul; 139(3):342-51. PubMed ID: 23374084 [TBL] [Abstract][Full Text] [Related]
38. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. Boaz MJ; Waters A; Murad S; Easterbrook PJ; Vyakarnam A J Immunol; 2002 Dec; 169(11):6376-85. PubMed ID: 12444145 [TBL] [Abstract][Full Text] [Related]
39. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024 [TBL] [Abstract][Full Text] [Related]
40. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection. Lacabaratz-Porret C; Urrutia A; Doisne JM; Goujard C; Deveau C; Dalod M; Meyer L; Rouzioux C; Delfraissy JF; Venet A; Sinet M J Infect Dis; 2003 Mar; 187(5):748-57. PubMed ID: 12599048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]